Kenneth Hess
0000-0003-1377-6070
3 papers found
Refreshing results…
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies
Postoperative MRI Evaluation of a Radiofrequency Cordotomy Lesion for Intractable Cancer Pain
Missing publications? Search for publications with a matching author name.